Arrowstreet Capital, Limited Partnership »

Entrada Therapeutics shares owned by Arrowstreet Capital, Limited Partnership

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Arrowstreet Capital, Limited Partnership from 13F filings

Historical chart of Arrowstreet Capital, Limited Partnership investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Arrowstreet Capital, Limited Partnership consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Arrowstreet Capital, Limited Partnership

Quarter filed Position value Share count Share price at filing
2024-03-31 $203k 14k 14.19

More positions owned by Arrowstreet Capital, Limited Partnership

Microsoft Corporation (MSFT)
Apple (AAPL)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Wells Fargo & Company (WFC)
JPMorgan Chase & Co. (JPM)
Booking Holdings (BKNG)
General Motors Company (GM)
Stellantis SHS (STLA)
Shopify Cl A (SHOP)
Comcast Corp Cl A (CMCSA)
UnitedHealth (UNH)
At&t (T)
Mastercard Incorporated Cl A (MA)
Citigroup Com New (C)

View all positions for Arrowstreet Capital, Limited Partnership

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
MPM Asset Management
5AM Venture Management
T. Rowe Price Associates
BlackRock
Redmile Group
Vanguard Group
Wellington Management Company
StepStone
TCG Crossover Management
Geode Capital Management
State Street Corporation
American Century Companies
Northern Trust
FMR

View all funds holding Entrada Therapeutics